Tokyo, Feb. 23 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060722) titled 'MASTARD-COVID: A Matched-Cohort Study of Treatment-requiring Autoimmune Rheumatic Diseases after COVID-19 Using Japanese Health Insurance Claims Data' on Feb. 21.
Study Type:
Observational
Primary Sponsor:
Institute - The University of Osaka
Condition:
Condition - Coronavirus disease 2019
autoimmune inflammatory rheumatic diseases
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Using the Japan Medical Data Center (JMDC) claims database derived from health insurance union-originated medical databases, COVID-19-infected and uninfected individuals were perfectly matc...